2-134718826-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM1BP4_ModerateBS2
The ENST00000281924.6(TMEM163):c.110G>A(p.Ser37Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000371 in 1,132,188 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000281924.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM163 | NM_030923.5 | c.110G>A | p.Ser37Asn | missense_variant | 1/8 | ENST00000281924.6 | NP_112185.1 | |
LOC105373629 | XR_923354.4 | n.456+259C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM163 | ENST00000281924.6 | c.110G>A | p.Ser37Asn | missense_variant | 1/8 | 1 | NM_030923.5 | ENSP00000281924 | P1 | |
ENST00000655237.1 | n.380+259C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000221 AC: 33AN: 149494Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000916 AC: 9AN: 982694Hom.: 0 Cov.: 30 AF XY: 0.00000433 AC XY: 2AN XY: 462268
GnomAD4 genome AF: 0.000221 AC: 33AN: 149494Hom.: 0 Cov.: 32 AF XY: 0.000192 AC XY: 14AN XY: 72848
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 14, 2022 | The c.110G>A (p.S37N) alteration is located in exon 1 (coding exon 1) of the TMEM163 gene. This alteration results from a G to A substitution at nucleotide position 110, causing the serine (S) at amino acid position 37 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at